Poster #3 – DIACCURATE : DIACC3010, optimized inhibitor of S6 kinase, combined with endocrine therapy, has potent antitumor activity in treatment-resistant ER+ HER2 – metastatic breast cancer
Poster #4 – BRENUS PHARMA : 1179 efficacity study of STC-1010 antitumor vaccine associated with standard chemotherapies on MC38 syngeneic colon cancer tumor model
Antineo chooses Repositive’s Cancer Models product to share cancer models with more oncology researchers
